[Form 4] DoubleVerify Holdings, Inc. Insider Trading Activity
Mark Zagorski, Chief Executive Officer and Director of DoubleVerify Holdings, Inc. (DV), was granted 161,708 restricted stock units on August 19, 2025. The restricted stock units convert into common stock on a one-for-one basis and carry a reported price of $0 for reporting purposes. Following the grant, Mr. Zagorski beneficially owns 161,708 shares of common stock subject to the award, held directly. 8.33% of the award vests on December 31, 2025, with the remainder vesting at 8.33% each quarterly anniversary thereafter, contingent on continued employment. The Form 4 was signed by an attorney-in-fact on August 21, 2025.
- Grant documented: 161,708 restricted stock units were granted on 08/19/2025
- Vesting schedule disclosed: 8.33% vests on 12/31/2025 and 8.33% each quarterly anniversary thereafter
- Conversion stated: Restricted stock units convert into common stock on a one‑for‑one basis
- Post‑transaction holdings: 161,708 shares beneficially owned following the transaction
- None.
Insights
TL;DR: Executive received a time‑based RSU award of 161,708 shares with quarterly vesting beginning Dec 31, 2025.
The grant of 161,708 restricted stock units to the CEO is a standard equity compensation disclosure showing time‑based vesting tied to continued employment. The RSUs convert 1:1 into common shares and begin vesting with an 8.33% tranche on December 31, 2025, then 8.33% quarterly thereafter. The report lists direct beneficial ownership of the awarded units and a $0 reported price, consistent with typical disclosure when shares are awarded rather than purchased.
TL;DR: This Form 4 documents a routine executive equity grant with time‑based vesting and direct ownership of awarded units.
The filing documents that the reporting person is both an officer (CEO) and a director and that the grant is subject to continued employment vesting. The record is a factual disclosure of insider ownership change and includes signature by an attorney‑in‑fact, indicating proper execution of the Form 4. No other conditions or derivative instruments are disclosed in the filing.